Not applicableStudy completedNCT05458531What this trial is testingMonitoring of Inflammatory ConditionsWho this might be right forInflammatory DiseaseCrohn DiseaseUlcerative Colitis+6 more University of Nottingham 664
Not applicableStudy completedNCT00003538What this trial is testingPrevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT03206359What this trial is testingGADD34 and Type I IFN Response Genes in SLEWho this might be right forSystemic Lupus Erythematosus University Hospital, Grenoble 90
Testing effectiveness (Phase 2)Study completedNCT01058343What this trial is testingSafety of IFNa Kinoid in Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Neovacs 28
Early research (Phase 1)Looking for participantsNCT07318259What this trial is testingStudy of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLEWho this might be right forSystemic Lupus Erythematosus Chongqing Precision Biotech Co., Ltd 18
Not applicableUnknownNCT02803346What this trial is testingEvaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)Who this might be right forImmunology of Septic Shock Hospices Civils de Lyon 160
Not applicableStudy completedNCT02364908What this trial is testingProspective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic LupusWho this might be right forSystemic Lupus Erythematosus University Hospital, Lille 158
Testing effectiveness (Phase 2)Active Not RecruitingNCT05798117What this trial is testingAn Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus ErythematosusWho this might be right forSystemic Lupus ErythematosusLupus Nephritis Novartis Pharmaceuticals 21
Not applicableStudy completedNCT02350491What this trial is testingStudy During Pregnancy of Expression of miRNAs in RA or SLEWho this might be right forRheumatoid ArthritisSystemic Lupus Erythematosus University Hospital, Strasbourg, France 50
Not applicableStudy completedNCT00935389What this trial is testingProspective Study of TW in the Treatment of LN Type V With Gross ProteinuriaWho this might be right forLupus NephritisProteinuriaCTX Nanjing University School of Medicine 44
Not applicableLooking for participantsNCT05099315What this trial is testingMicrobiome in Atopic Dermatitis Under Systemic TherapyWho this might be right forAtopic Dermatitis Charite University, Berlin, Germany 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT05417906What this trial is testingUsing the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma ExacerbationsWho this might be right forAsthma AttackAsthma Changi General Hospital 110
Large-scale testing (Phase 3)Looking for participantsNCT06561048What this trial is testingSoquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell LymphomaWho this might be right forPeripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell LymphomaFollicular T-Cell Lymphoma+4 more Corvus Pharmaceuticals, Inc. 150
Early research (Phase 1)Ended earlyNCT00684255What this trial is testingReduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)Who this might be right forSystemic Lupus ErythematosusSystemic Sclerosis New York Medical College 1
Testing effectiveness (Phase 2)Study completedNCT04975555What this trial is testingStudy to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell TherapyWho this might be right forCytokine Release SyndromeICANSLymphoma, Non-Hodgkin+2 more University of Alabama at Birmingham 20
Not applicableNot Yet RecruitingNCT07505576What this trial is testingAnti-alpha-actinin Antibodies and Lupus Nephritis ActivityWho this might be right forLupus Nephritis Assiut University 96
Testing effectiveness (Phase 2)Study completedNCT00132015What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic MastocytosisWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more National Institutes of Health Clinical Center (CC) 37
Testing effectiveness (Phase 2)Study completedNCT00564889What this trial is testingLenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic AmyloidosisWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Mayo Clinic 35
Not applicableStudy completedNCT04400240What this trial is testingCare Coordination Approaches to Learning Lupus Self-managementWho this might be right forSystemic Lupus Erythematosus Medical University of South Carolina 30
Not applicableNot Yet RecruitingNCT07685288What this trial is testingEffect of a Weekly Yoga Program Integrated Into Standard Care on Disease Activity, Fatigue, Mood, and Treatment Adherence in Patients With Systemic Autoimmune and Inflammatory Diseases: A Prospective Observational StudyWho this might be right forAuto Immune DiseaseAuto-inflammatory Disease Assistance Publique - Hôpitaux de Paris 100